Gingivitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Systemically healthy individuals; presence of gingival inflammation in more than 30% of the sites; presence of 20 permanent teeth fully erupted, excluding third molars and teeth indicated for extraction; willingness to adhere to the study protocol.
Exclusion criteria
Exclusion criteria: Pregnant or lactating women; individuals with systemic involvement that may interfere with the study results; ingestion of antimicrobials and/or anti-inflammatories in the last 6 months and probiotics or oral antiseptics in the last month; use of medication with gingival implications; history or presence of periodontitis; presence of gingival disease not induced by plaque; known allergies to experimental materials; extensive prosthetic wraps; smoking.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: Reduction in bleeding on probing; assessed dichotomously at 6 sites per tooth; considering a variation of at least 15% in the data collected at the beginning and at the end of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 1: Reduction in the percentage of plaque; assessed by the Ainamo and Bay Visible Plaque Index at 4 sites per tooth; at the beginning and end of the study.;Expected outcome 2: Reduction in gingival inflammation; evaluated by the reduction in the levels of cytokines IL-1b, IL-1a, IL-8, RANTES, MCP-1 and MIP-1b present in the gingival crevicular fluid, through enzymatic immunoassays; at the beginning and end of the study.;Expected outcome 3: Reduction in the proportion of bacteria associated with periodontal disease and increase in the proportion of bacteria associated with periodontal health in dental biofilm; assessed by sequencing the 16S RNA gene; at the beginning and end of the study. | — |
Countries
Brazil
Contacts
Universidade de São Paulo